| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 |
|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities: | |||||||
Net income | |||||||
313 | 567 | 858 | 825 | 628 | 0 | 0 | 0 |
Adjustments to reconcile net income to net cash used in operating activities: | |||||||
Interest earned on marketable securities held in Trust Account | |||||||
1,105 | 1,246 | 1,286 | 1,270 | 0 | 0 | 0 | - |
Unrealized gain on marketable securities held in Trust Account | |||||||
35 | 6 | 25 | 1 | 0 | 0 | 0 | - |
Changes in operating assets and liabilities: | |||||||
Prepaid expenses and other current assets | |||||||
-31 | -42 | -76 | 54 | 0 | 0 | 0 | - |
Accounts payable and accrued expenses | |||||||
86 | 74 | 29 | 1 | 0 | 0 | 0 | - |
Net cash used in operating activities | |||||||
-709 | -567 | -347 | -499 | -392 | 0 | 0 | 0 |
Cash Flows from Investing Activities: | |||||||
Investment of cash in Trust Account | |||||||
- | - | - | 55,000 | 0 | 0 | 0 | - |
Net cash provided by (used in) investing activities | |||||||
- | - | - | -55,000 | 0 | 0 | 0 | - |
Cash Flows from Financing Activities: | |||||||
Proceeds from sale of Units, net of underwriting discounts paid | |||||||
- | - | - | 53,625 | 0 | 0 | 0 | - |
Proceeds from sale of Private Warrants | |||||||
- | - | - | 2,375 | 0 | 0 | 0 | - |
Proceeds from sale of unit purchase option | |||||||
- | - | - | 0 | 0 | 0 | 0 | - |
Proceeds from issuance of Founder Shares | |||||||
- | - | - | - | - | - | - | 0 |
Payment of offering costs | |||||||
- | - | - | 335 | 504 | 0 | 0 | 0 |
Proceeds from convertible promissory notes – related party | |||||||
0 | 0 | 0 | - | - | - | - | 0 |
Proceeds from promissory notes – related party | |||||||
- | - | - | - | - | - | - | 0 |
Repayment of promissory notes – related party | |||||||
- | - | - | 125 | 0 | 0 | 0 | - |
Repayment of advances from related party | |||||||
- | - | - | 75 | 0 | 0 | 0 | - |
Net cash (used in) provided by financing activities | |||||||
-2,914 | 650 | 50 | 55,464 | 55,520 | 0 | 0 | 0 |
Net Change in Cash | |||||||
-79 | 82 | -297 | -34 | 128 | 0 | 0 | 0 |
Supplemental disclosure of noncash investing and financing activities: | |||||||
Initial classification of ordinary shares subject to possible redemption | |||||||
- | - | - | 50,515 | 0 | 0 | 0 | - |
Change in value of ordinary shares subject to possible redemption | |||||||
313 | 567 | 858 | 825 | 0 | 0 | 0 | - |
Deferred offering costs included in accrued offering costs | |||||||
- | - | - | - | - | - | - | 0 |